Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5734386 | Surgery | 2017 | 14 Pages |
Abstract
Currently, no specific technique can eliminate development of clinically relevant postoperative pancreatic fistula. While consistent practice of any standardized technique may decrease the rate of clinically relevant postoperative pancreatic fistula, experienced surgeons can have lower postoperative pancreatic fistula rates performing a variety of techniques depending on the clinical situation. There is no clear evidence on the benefit of internal or external stenting after pancreatico-enteric anastomosis. The use of somatostatin analogues may be important in decreasing morbidity after pancreatoduodenectomy, but it remains controversial. Future studies should focus on novel approaches to decrease the rate of clinically relevant postoperative pancreatic fistula with appropriate risk adjustment.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Shailesh V. MD, Masillamany MD, Charles M. MD, Helmut MD, Marc G. MD, Abe MD, Charles J. MD, Carlos MD, Christos MD, Christoper MD, Dirk J. MD, Dejan MD, Horacio J. MD, John P. MD, Jakob R. MD, Keith D. MD, Kevin C. MD, Laureano MD, Markus W. MD,